Sale

Global Gatifloxacin Market by Route of Administration (Intravenous, Ophthalmic, Oral), Form (Solution, Tablet), Indication, Sales Channel - Forecast 2024-2030

Report
187 Pages
May 2024
Region: Global
360iResearch™
ID: 5967939

UP TO €830EUR$875USD£707GBP OFF until Dec 31^st 2024

The Gatifloxacin Market size was estimated at USD 315.49 million in 2023, USD 331.32 million in 2024, and is expected to grow at a CAGR of 4.88% to reach USD 440.46 million by 2030.

Gatifloxacin is an antibiotic belonging to the fluoroquinolone class of medications. It is designed to combat bacterial infections by inhibiting the enzymes necessary for bacterial DNA replication, repair, and transcription. This action helps to eliminate bacterial growth and treat infections. Gatifloxacin is commonly used to treat infections, including conjunctivitis, pink eye, and respiratory tract infections. Increasing demand for gatifloxacin due to broad-spectrum antibacterial properties and supportive reforms in healthcare infrastructure enhancing access to antibiotics such as gatifloxacin, further propelling the market growth.

However, rising product recall issues due to safety concerns the, the prevalence of counterfeit products, and production issues hinder the market growth. Nevertheless, continuous advancements in the production technologies of gatifloxacin and rising partnerships between pharmaceutical companies and academic or research institutions create potential growth avenues for the gatifloxacin market.

Regional Insights

In the Americas, the U.S. and Canada maintain robust growth in gatifloxacin, supported by advanced healthcare systems and ongoing antibiotic efficacy and safety research. The gatifloxacin market is also influenced by regulatory frameworks that promote the careful use of antibiotics to prevent resistance buildup. Investment trends include the development of combination drugs and the exploration of new therapeutic areas. In the EMEA region, the gatifloxacin market is influenced by differing economic conditions, healthcare systems, and regulatory standards. EU countries emphasize stringent control and innovative research, while the Middle East and Africa are working towards improving healthcare access and handling prevalent infections.

Investments focus on enhancing healthcare facilities and integrating global health initiatives to increase the availability of effective treatments, including gatifloxacin. The APAC region shows an evolving growth of gatifloxacin driven by large populations and rising healthcare needs. The region’s diverse economic landscapes mean that while advanced economies focus on innovation and improving existing treatments, emerging markets prioritize access and affordability. Investments are heavily directed towards expanding healthcare infrastructure and researching new drug applications.

Market Trends by Segment

Form: Burgeoning preference for the table form of gatifloxacin due to the easy administration
Indication: Proliferating usage of gatifloxacin to treat eye infections

Industry Insights

Market Dynamics
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
Market Share Analysis
Strategy Analysis and Recommendations

Recent Developments

Escalation of Pink Eye Cases in eThekwini Prompts Public Health Advisory

eThekwini witnessed a noteworthy surge in cases of pink eye (conjunctivitis), prompting health authorities to issue alerts and advice to the public. Initially identified in several educational institutions, the outbreak has affected numerous individuals, leading to concerns about wider community spread. The KwaZulu-Natal Department of Health confirmed the incidents, urging the public to adhere to hygiene practices such as frequent hand washing and avoiding contact with those infected. Measures are being implemented to contain the outbreak and prevent further transmission, with health officials closely monitoring the situation.

Sandoz Enhances U.S. Market Presence through Exclusive Commercialization Rights for Six Products

Sandoz, a global entity in the generics and biosimilars industry, secured an exclusive agreement with Adalvo to commercialize six pivotal healthcare products in the United States, focusing on anti-infectives, oncology, and pulmonary treatments. This initiative is set to bolster patient access to essential, cost-effective medications and drive sustainability in global healthcare systems.

Key Company Profiles

The report delves into recent significant developments in the Gatifloxacin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adore Pharmaceuticals Pvt. Ltd., Allergan, Inc., Apotex Inc., Bristol-Myers Squibb Company, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Knox Life Sciences, Lupin Pharmaceuticals, Inc., Mylan N.V., Novartis AG, Roche Holding AG, and Sandoz International GmbH.

This research report offers invaluable insights into various crucial aspects of the Gatifloxacin Market:

Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current market size and projected growth?
Which products, segments, applications, and regions offer promising investment opportunities?
What are the prevailing technology trends and regulatory frameworks?
What is the market share and positioning of the leading vendors?
What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for gatifloxacin due to broad-spectrum antibacterial properties
5.1.1.2. Supportive reforms in healthcare infrastructure enhancing access to antibiotics
5.1.2. Restraints
5.1.2.1. Product recalls due to safety concerns
5.1.3. Opportunities
5.1.3.1. Continuous advancements in production technologies of gatifloxacin
5.1.3.2. Partnerships between pharmaceutical companies and academic or research institutions
5.1.4. Challenges
5.1.4.1. Prevalence of counterfeit products and production issues
5.2. Market Segmentation Analysis
5.2.1. Form: Burgeoning preference for the table form of gatifloxacin due to the easy administration
5.2.2. Indication: Proliferating usage of gatifloxacin to treat eye infections
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Gatifloxacin Market, by Route of Administration

6.1. Introduction
6.2. Intravenous
6.3. Ophthalmic
6.4. Oral

7. Gatifloxacin Market, by Form

7.1. Introduction
7.2. Solution
7.3. Tablet

8. Gatifloxacin Market, by Indication

8.1. Introduction
8.2. Eye Infections
8.3. Respiratory Infections
8.4. Sinus Infections
8.5. Skin Infections

9. Gatifloxacin Market, by Sales Channel

9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Stores
9.4. Retail Pharmacy

10. Americas Gatifloxacin Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Gatifloxacin Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Gatifloxacin Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Escalation of Pink Eye Cases in eThekwini Prompts Public Health Advisory
13.3.2. Sandoz Enhances U.S. Market Presence through Exclusive Commercialization Rights for Six Products
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio

List of Figures

FIGURE 1. GATIFLOXACIN MARKET RESEARCH PROCESS
FIGURE 2. GATIFLOXACIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GATIFLOXACIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GATIFLOXACIN MARKET DYNAMICS
FIGURE 7. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GATIFLOXACIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GATIFLOXACIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. GATIFLOXACIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. GATIFLOXACIN MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. GATIFLOXACIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GATIFLOXACIN MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GATIFLOXACIN MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GATIFLOXACIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GATIFLOXACIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GATIFLOXACIN MARKET SIZE, BY SOLUTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GATIFLOXACIN MARKET SIZE, BY SOLUTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GATIFLOXACIN MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GATIFLOXACIN MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GATIFLOXACIN MARKET SIZE, BY EYE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GATIFLOXACIN MARKET SIZE, BY EYE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GATIFLOXACIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GATIFLOXACIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GATIFLOXACIN MARKET SIZE, BY SINUS INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GATIFLOXACIN MARKET SIZE, BY SINUS INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GATIFLOXACIN MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GATIFLOXACIN MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL GATIFLOXACIN MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL GATIFLOXACIN MARKET SIZE, BY ONLINE STORES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 65. CANADA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 66. CANADA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 67. CANADA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 68. CANADA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 69. CANADA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 70. CANADA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 71. CANADA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 72. CANADA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 73. MEXICO GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 74. MEXICO GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 75. MEXICO GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 76. MEXICO GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 77. MEXICO GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 78. MEXICO GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 79. MEXICO GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 80. MEXICO GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 109. CHINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 110. CHINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 111. CHINA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 112. CHINA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 113. CHINA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 114. CHINA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 115. CHINA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 116. CHINA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 117. INDIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 118. INDIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 119. INDIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 120. INDIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 121. INDIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 122. INDIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 123. INDIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 124. INDIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 133. JAPAN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 134. JAPAN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 135. JAPAN GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 136. JAPAN GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 137. JAPAN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 138. JAPAN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 139. JAPAN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 140. JAPAN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 181. THAILAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 182. THAILAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 183. THAILAND GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 184. THAILAND GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 185. THAILAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. THAILAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. THAILAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 188. THAILAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 207. DENMARK GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 208. DENMARK GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 209. DENMARK GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 210. DENMARK GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 211. DENMARK GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 212. DENMARK GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 213. DENMARK GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 214. DENMARK GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 215. EGYPT GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 216. EGYPT GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 217. EGYPT GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 218. EGYPT GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 219. EGYPT GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 220. EGYPT GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 221. EGYPT GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 222. EGYPT GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 223. FINLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 224. FINLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 225. FINLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 226. FINLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 227. FINLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. FINLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. FINLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 230. FINLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 231. FRANCE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 232. FRANCE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 233. FRANCE GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 234. FRANCE GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 235. FRANCE GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 236. FRANCE GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 237. FRANCE GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 238. FRANCE GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 239. GERMANY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 240. GERMANY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 241. GERMANY GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 242. GERMANY GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 243. GERMANY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 244. GERMANY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 245. GERMANY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 246. GERMANY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 255. ITALY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 256. ITALY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 257. ITALY GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 258. ITALY GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 259. ITALY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 260. ITALY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 261. ITALY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 262. ITALY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 279. NORWAY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 280. NORWAY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 281. NORWAY GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 282. NORWAY GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 283. NORWAY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 284. NORWAY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 285. NORWAY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 286. NORWAY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 287. POLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 288. POLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 289. POLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 290. POLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 291. POLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 292. POLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 293. POLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 294. POLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 295. QATAR GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 296. QATAR GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 297. QATAR GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 298. QATAR GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 299. QATAR GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 300. QATAR GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 301. QATAR GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 302. QATAR GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 327. SPAIN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 328. SPAIN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 329. SPAIN GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 330. SPAIN GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 331. SPAIN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 332. SPAIN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 333. SPAIN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 334. SPAIN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 351. TURKEY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 352. TURKEY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 353. TURKEY GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 354. TURKEY GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 355. TURKEY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 356. TURKEY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 357. TURKEY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 358. TURKEY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
TABLE 367. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 368. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 369. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 370. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 371. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 372. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 373. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY SALE

Companies Mentioned

Abbott Laboratories
Adore Pharmaceuticals Pvt. Ltd.
Allergan, Inc.
Apotex Inc.
Bristol-Myers Squibb Company
Cipla Ltd.
Dr. Reddy's Laboratories Ltd.
Knox Life Sciences
Lupin Pharmaceuticals, Inc.
Mylan N.V.
Novartis AG
Roche Holding AG
Sandoz International GmbH

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	187
Published	May 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 331.32 Million
Forecasted Market Value ( USD ) by 2030	$ 440.46 Million
Compound Annual Growth Rate	4.8%
Regions Covered	Global
No. of Companies Mentioned	13

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Month

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3201EUR$3,374USD£2,726GBP €3557EUR$3,749USD£3,029GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4055EUR$4,274USD£3,453GBP €4506EUR$4,749USD£3,837GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4909EUR$5,174USD£4,181GBP €5455EUR$5,749USD£4,645GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5763EUR$6,074USD£4,908GBP €6403EUR$6,749USD£5,453GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Month	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one month.	This is an enterprise license, allowing all employees within your organization access to the product.	€7471EUR$7,874USD£6,362GBP €8301EUR$8,749USD£7,069GBP

Regional Insights

Market Trends by Segment

Industry Insights

Recent Developments

Escalation of Pink Eye Cases in eThekwini Prompts Public Health Advisory

Sandoz Enhances U.S. Market Presence through Exclusive Commercialization Rights for Six Products

Key Company Profiles

This research report offers invaluable insights into various crucial aspects of the Gatifloxacin Market:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Gatifloxacin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Gatifloxacin (CAS 112811-59-3) Global Market Research Report 2024

Global Sulphonamides Market by Form (Capsule, Liquid, Powder), Route of Administration (Oral, Topical), Distribution Channel, Application - Forecast 2024-2030

Global Vancomycin Market by Type (Ampicillin, Chloramphenicol, Daptomycin), Form (Capsule, Oral Solution (Liquid), Powder), Route of Administration, Application, Distribution Channel - Forecast 2024-2030

Global Cephalosporin Drug Market (2024 Edition): Analysis by Generation, Route of Administration, Application (Respiratory Tract Infection, Skin Infection, Urinary Tract Infection, Others), By Region, By Country: Market Insights and Forecast (2019-2029)

About the Gatifloxacin Market